-
Symbol
-
PRLD on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Deerfield Mgmt, L.P. ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)
13 Feb 2025 - Deerfield Mgmt, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).
This represents 0% ownership of the company.
This is the first filing by James E. Flynn disclosing ownership of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).